Therefore, the aim of this study was to determine the involvement of these variants at CDKN2A/B locus in the susceptibility of B-ALL in our Spanish population and explore if SNPs in miRNA binding sites could be also involved in B-ALL risk. This evidence concerns the gene CDKN2A and precursor B-cell acute lymphoblastic leukemia.